{"version":"1.0","provider_name":"Xspray","provider_url":"https:\/\/xspraypharma.com\/sv\/","author_name":"awave_admin","author_url":"https:\/\/xspraypharma.com\/sv\/author\/awave_admin\/","title":"F\u00f6r\u00e4ndrat antal aktier i Xspray Pharma AB (publ) - Xspray","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"FdiB6XwtXk\"><a href=\"https:\/\/xspraypharma.com\/sv\/pressmeddelande\/forandrat-antal-aktier-i-xspray-pharma-ab-publ\/\">F\u00f6r\u00e4ndrat antal aktier i Xspray Pharma AB (publ)<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/xspraypharma.com\/sv\/pressmeddelande\/forandrat-antal-aktier-i-xspray-pharma-ab-publ\/embed\/#?secret=FdiB6XwtXk\" width=\"600\" height=\"338\" title=\"\u201dF\u00f6r\u00e4ndrat antal aktier i Xspray Pharma AB (publ)\u201d &ndash; Xspray\" data-secret=\"FdiB6XwtXk\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"F\u00f6r ytterligare information, v\u00e4nligen kontakta: Per Andersson, vd, Xspray Pharma AB (publ) Tel: 0706 88 23 48 E-mail: per.andersson@xspray.com Denna information \u00e4r s\u00e5dan som Xspray Pharma AB (publ) \u00e4r skyldigt att offentligg\u00f6ra enligt Lagen om v\u00e4rdepappersmarknaden. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 31 maj 2018 kl. 18:30. Xspray Pharma i korthet\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Xspray [&hellip;]"}